Arrowstreet Capital’s Vaxart VXRT Stock Holding History

Arrowstreet Capital’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,207,646	Closed	-$8.03M	–	2565
2020 Q3	$8.03M	Buy	+1,207,646	New	+$10.8M	0.01%	944

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Arrowstreet Capital's VXRT Position: Q4 2020 in Review

Arrowstreet Capital sold out of Vaxart (VXRT) in Q4 2020, closing a stake of 1,207,646 shares — an estimated $8.03M sold.

Arrowstreet Capital first reported a position in VXRT in Q3 2020 and held it in 1 quarter. The position peaked at $8.03M in Q3 2020. 141 funds tracked by Wall St. Rank hold VXRT as of Q4 2020.

Arrowstreet Capital reported no remaining Vaxart position as of Q4 2020 after selling out during the quarter.
Arrowstreet Capital sold 1,207,646 Vaxart shares in Q4 2020, an estimated $8.03M.
Arrowstreet Capital first reported a position in Vaxart in Q3 2020 and held it in 1 quarter.
Arrowstreet Capital's Vaxart position peaked at $8.03M in Q3 2020.
141 funds tracked by Wall St. Rank held Vaxart as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.